vs
Side-by-side financial comparison of APTARGROUP, INC. (ATR) and iQIYI, Inc. (IQ). Click either name above to swap in a different company.
iQIYI, Inc. is the larger business by last-quarter revenue ($971.6M vs $962.7M, roughly 1.0× APTARGROUP, INC.).
AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.
iQIYI, Inc.IQEarnings & Financial Report
iQIYI, formerly Qiyi, is a Chinese subscription video on-demand over-the-top streaming service owned by Baidu. Headquartered in Beijing, iQIYI primarily produces and distributes films and television series.
ATR vs IQ — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $962.7M | $971.6M |
| Net Profit | $74.3M | — |
| Gross Margin | — | — |
| Operating Margin | 11.0% | 0.8% |
| Net Margin | 7.7% | — |
| Revenue YoY | 13.5% | — |
| Net Profit YoY | -26.4% | — |
| EPS (diluted) | $1.13 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $971.6M | ||
| Q4 25 | $962.7M | — | ||
| Q3 25 | $961.1M | — | ||
| Q2 25 | $966.0M | — | ||
| Q1 25 | $887.3M | $906.0M | ||
| Q4 24 | $848.1M | — | ||
| Q3 24 | $909.3M | — | ||
| Q2 24 | $910.1M | — |
| Q1 26 | — | — | ||
| Q4 25 | $74.3M | — | ||
| Q3 25 | $127.9M | — | ||
| Q2 25 | $111.7M | — | ||
| Q1 25 | $78.8M | — | ||
| Q4 24 | $100.9M | — | ||
| Q3 24 | $100.0M | — | ||
| Q2 24 | $90.5M | — |
| Q1 26 | — | 0.8% | ||
| Q4 25 | 11.0% | — | ||
| Q3 25 | 14.2% | — | ||
| Q2 25 | 14.9% | — | ||
| Q1 25 | 12.8% | 4.3% | ||
| Q4 24 | 14.2% | — | ||
| Q3 24 | 15.2% | — | ||
| Q2 24 | 13.8% | — |
| Q1 26 | — | — | ||
| Q4 25 | 7.7% | — | ||
| Q3 25 | 13.3% | — | ||
| Q2 25 | 11.6% | — | ||
| Q1 25 | 8.9% | — | ||
| Q4 24 | 11.9% | — | ||
| Q3 24 | 11.0% | — | ||
| Q2 24 | 9.9% | — |
| Q1 26 | — | — | ||
| Q4 25 | $1.13 | — | ||
| Q3 25 | $1.92 | — | ||
| Q2 25 | $1.67 | — | ||
| Q1 25 | $1.17 | — | ||
| Q4 24 | $1.48 | — | ||
| Q3 24 | $1.48 | — | ||
| Q2 24 | $1.34 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $409.5M | $4.4M |
| Total DebtLower is stronger | $1.1B | — |
| Stockholders' EquityBook value | $2.7B | $13.3M |
| Total Assets | $5.3B | $46.7M |
| Debt / EquityLower = less leverage | 0.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $4.4M | ||
| Q4 25 | $409.5M | — | ||
| Q3 25 | $264.8M | — | ||
| Q2 25 | $169.8M | — | ||
| Q1 25 | $136.8M | $3.5M | ||
| Q4 24 | $226.2M | — | ||
| Q3 24 | $327.9M | — | ||
| Q2 24 | $223.9M | — |
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | — | ||
| Q3 25 | $546.0M | — | ||
| Q2 25 | $535.1M | — | ||
| Q1 25 | $561.2M | — | ||
| Q4 24 | $688.1M | — | ||
| Q3 24 | $822.7M | — | ||
| Q2 24 | $681.5M | — |
| Q1 26 | — | $13.3M | ||
| Q4 25 | $2.7B | — | ||
| Q3 25 | $2.8B | — | ||
| Q2 25 | $2.7B | — | ||
| Q1 25 | $2.5B | $13.4M | ||
| Q4 24 | $2.5B | — | ||
| Q3 24 | $2.5B | — | ||
| Q2 24 | $2.4B | — |
| Q1 26 | — | $46.7M | ||
| Q4 25 | $5.3B | — | ||
| Q3 25 | $5.1B | — | ||
| Q2 25 | $4.9B | — | ||
| Q1 25 | $4.5B | $45.8M | ||
| Q4 24 | $4.4B | — | ||
| Q3 24 | $4.6B | — | ||
| Q2 24 | $4.5B | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.20× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 0.32× | — | ||
| Q2 24 | 0.28× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $183.7M | — |
| Free Cash FlowOCF − Capex | $96.9M | — |
| FCF MarginFCF / Revenue | 10.1% | — |
| Capex IntensityCapex / Revenue | 9.0% | — |
| Cash ConversionOCF / Net Profit | 2.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $299.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $183.7M | — | ||
| Q3 25 | $177.6M | — | ||
| Q2 25 | $126.0M | — | ||
| Q1 25 | $82.7M | — | ||
| Q4 24 | $178.2M | — | ||
| Q3 24 | $229.3M | — | ||
| Q2 24 | $143.6M | — |
| Q1 26 | — | — | ||
| Q4 25 | $96.9M | — | ||
| Q3 25 | $114.3M | — | ||
| Q2 25 | $62.5M | — | ||
| Q1 25 | $25.9M | — | ||
| Q4 24 | $112.2M | — | ||
| Q3 24 | $162.7M | — | ||
| Q2 24 | $75.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | 10.1% | — | ||
| Q3 25 | 11.9% | — | ||
| Q2 25 | 6.5% | — | ||
| Q1 25 | 2.9% | — | ||
| Q4 24 | 13.2% | — | ||
| Q3 24 | 17.9% | — | ||
| Q2 24 | 8.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | 9.0% | — | ||
| Q3 25 | 6.6% | — | ||
| Q2 25 | 6.6% | — | ||
| Q1 25 | 6.4% | — | ||
| Q4 24 | 7.8% | — | ||
| Q3 24 | 7.3% | — | ||
| Q2 24 | 7.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | 2.47× | — | ||
| Q3 25 | 1.39× | — | ||
| Q2 25 | 1.13× | — | ||
| Q1 25 | 1.05× | — | ||
| Q4 24 | 1.77× | — | ||
| Q3 24 | 2.29× | — | ||
| Q2 24 | 1.59× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
IQ
Segment breakdown not available.
